Ilkka Heinonen1,2,3, Bengt Saltin4, Ylva Hellsten5, Kari K Kalliokoski6. 1. Turku PET Centre, University of Turku, PO Box 52, 20521, Turku, Finland. ilkka.heinonen@utu.fi. 2. Department of Clinical Physiology and Nuclear Medicine, University of Turku, Turku, Finland. ilkka.heinonen@utu.fi. 3. Division of Experimental Cardiology, Thoraxcenter, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. ilkka.heinonen@utu.fi. 4. Copenhagen Muscle Research Center, University of Copenhagen, Copenhagen, Denmark. 5. Exercise and Sport Sciences, Section of Human Physiology, University of Copenhagen, Copenhagen, Denmark. 6. Turku PET Centre, University of Turku, PO Box 52, 20521, Turku, Finland.
Abstract
PURPOSE: Animal studies suggest that the inhibition of nitric oxide synthase (NOS) affects blood flow differently in different skeletal muscles according to their muscle fibre type composition (oxidative vs glycolytic). Quadriceps femoris (QF) muscle consists of four different muscle parts: vastus intermedius (VI), rectus femoris (RF), vastus medialis (VM), and vastus lateralis (VL) of which VI is located deep within the muscle group and is generally regarded to consist mostly of oxidative muscle fibres. METHODS: We studied the effect of NOS inhibition on blood flow in these four different muscles by positron emission tomography in eight young healthy men at rest and during one-leg dynamic exercise, with and without combined blockade with prostaglandins. RESULTS: At rest blood flow in the VI (2.6 ± 1.1 ml/100 g/min) was significantly higher than in VL (1.9 ± 0.6 ml/100 g/min, p = 0.015) and RF (1.7 ± 0.6 ml/100 g/min, p = 0.0015), but comparable to VM (2.4 ± 1.1 ml/100 g/min). NOS inhibition alone or with prostaglandins reduced blood flow by almost 50% (p < 0.001), but decrements were similar in all four muscles (drug × muscle interaction, p = 0.43). During exercise blood flow was also the highest in VI (45.4 ± 5.5 ml/100 g/min) and higher compared to VL (35.0 ± 5.5 ml/100 g/min), RF (38.4 ± 7.4 ml/100 g/min), and VM (36.2 ± 6.8 ml/100 g/min). NOS inhibition alone did not reduce exercise hyperemia (p = 0.51), but combined NOS and prostaglandin inhibition reduced blood flow during exercise (p = 0.002), similarly in all muscles (drug × muscle interaction, p = 0.99). CONCLUSION: NOS inhibition, with or without prostaglandins inhibition, affects blood flow similarly in different human QF muscles both at rest and during low-to-moderate intensity exercise.
PURPOSE: Animal studies suggest that the inhibition of nitric oxide synthase (NOS) affects blood flow differently in different skeletal muscles according to their muscle fibre type composition (oxidative vs glycolytic). Quadriceps femoris (QF) muscle consists of four different muscle parts: vastus intermedius (VI), rectus femoris (RF), vastus medialis (VM), and vastus lateralis (VL) of which VI is located deep within the muscle group and is generally regarded to consist mostly of oxidative muscle fibres. METHODS: We studied the effect of NOS inhibition on blood flow in these four different muscles by positron emission tomography in eight young healthy men at rest and during one-leg dynamic exercise, with and without combined blockade with prostaglandins. RESULTS: At rest blood flow in the VI (2.6 ± 1.1 ml/100 g/min) was significantly higher than in VL (1.9 ± 0.6 ml/100 g/min, p = 0.015) and RF (1.7 ± 0.6 ml/100 g/min, p = 0.0015), but comparable to VM (2.4 ± 1.1 ml/100 g/min). NOS inhibition alone or with prostaglandins reduced blood flow by almost 50% (p < 0.001), but decrements were similar in all four muscles (drug × muscle interaction, p = 0.43). During exercise blood flow was also the highest in VI (45.4 ± 5.5 ml/100 g/min) and higher compared to VL (35.0 ± 5.5 ml/100 g/min), RF (38.4 ± 7.4 ml/100 g/min), and VM (36.2 ± 6.8 ml/100 g/min). NOS inhibition alone did not reduce exercise hyperemia (p = 0.51), but combined NOS and prostaglandin inhibition reduced blood flow during exercise (p = 0.002), similarly in all muscles (drug × muscle interaction, p = 0.99). CONCLUSION: NOS inhibition, with or without prostaglandins inhibition, affects blood flow similarly in different human QF muscles both at rest and during low-to-moderate intensity exercise.
Authors: M Harold Laughlin; Michael J Davis; Niels H Secher; Johannes J van Lieshout; Arturo A Arce-Esquivel; Grant H Simmons; Shawn B Bender; Jaume Padilla; Robert J Bache; Daphne Merkus; Dirk J Duncker Journal: Compr Physiol Date: 2012-01 Impact factor: 9.090
Authors: Ilkka Heinonen; Marco Bucci; Jukka Kemppainen; Juhani Knuuti; Pirjo Nuutila; Robert Boushel; Kari K Kalliokoski Journal: J Appl Physiol (1985) Date: 2012-01-05
Authors: Steven W Copp; Daniel M Hirai; K Sue Hageman; David C Poole; Timothy I Musch Journal: Am J Physiol Regul Integr Comp Physiol Date: 2009-12-09 Impact factor: 3.619
Authors: Ilkka Heinonen; Jukka Kemppainen; Kimmo Kaskinoro; Juha E Peltonen; Ronald Borra; Markus M Lindroos; Vesa Oikonen; Pirjo Nuutila; Juhani Knuuti; Ylva Hellsten; Robert Boushel; Kari K Kalliokoski Journal: J Appl Physiol (1985) Date: 2009-11-25
Authors: Scott K Ferguson; Clark T Holdsworth; Jennifer L Wright; Alex J Fees; Jason D Allen; Andrew M Jones; Timothy I Musch; David C Poole Journal: Nitric Oxide Date: 2014-10-02 Impact factor: 4.427
Authors: Ilkka Heinonen; Maria Wendelin-Saarenhovi; Kimmo Kaskinoro; Juhani Knuuti; Mika Scheinin; Kari K Kalliokoski Journal: Am J Physiol Heart Circ Physiol Date: 2013-05-10 Impact factor: 4.733
Authors: Andrew M Jones; Scott K Ferguson; Stephen J Bailey; Anni Vanhatalo; David C Poole Journal: Exerc Sport Sci Rev Date: 2016-04 Impact factor: 6.230
Authors: Katrina J Carter; Aaron T Ward; J Mikhail Kellawan; Marlowe W Eldridge; Awni Al-Subu; Benjamin J Walker; Jeffrey W Lee; Oliver Wieben; William G Schrage Journal: J Physiol Date: 2021-10-13 Impact factor: 6.228